University of ColoradoUSA
Dr. Xiyuan Bai is an Associate Professor of Medical Research in the Department of Medicine at the University of Colorado School of Medicine and Senior Scientist at the Denver VA Medical center and National Jewish Health. He received his Ph.D. in the institute of molecular microbiology and biotechnology from WestfaelischeWilhelms-University of Muenster, Germany. He did his postdoctoral training at institute of genetic, biochemistry and microbiology of Universityof Nuerberg-Erlangeng, Germany, and at McLaughlin Research Institute for Biomedical Science Great Falls, Montana. His area of expertise is cellular and molecular biology, basic immunology and inflammation, animal modeling, respiratory bacterial infections.His main research interests are pulmonary infectious disease-Mycobacteriumtuberculosis (MTB) and Nontuberculosis mycobacteria (NTM), host- pathogen interaction, gene regulation and signal transduction, drug discovery against mycobacteria, and protein-protein (DNA/RNA) interaction.
University of ConnecticutUSA
James received his PhD in Immunology from the University of Connecticut and have published extensively in the field of applied immunology using immuno-microarrays in combination with surface plasmon based detection systems. His recent work has focused on the regulation of zinc signaling in the context of CD4+ T cell effector cell development and adaptive immune responses. He is currently collaborating on a nanoparticle vaccine study to evaluate the immune responses to nanoparticle delivered peptide or mRNA based vaccines in controlling tumor growth in animal models of lymphoma and prostate cancer.
University of ThessalyGreece
Hadjigeorgiou received his MD and PhD from Medical School, National and Kapodistrian University of Athens, Greece. He worked as post-doc research fellow (neurogenetics) at University of Milan, Italy and Columbia University, New York. Currently, he is Professor and Head of Department of Neurology and Director of the Neuroscience Unit of the Medical School, University of Thessaly.
Okazaki Medical ClinicJapan
Kimihiko Okazaki has Graduated from Kyoto University Faculty of Medicine in 1959.He engaged in medical chemical research during April,1960-July,1981.His main achievements are 1. Discovery of a novel coenzyme of thiamine pyrophosphokinase, i.e. myo-inositol 1-pyrophosphate in Baker's yeast. 2. Identification of initiator of rat liver regeneration as biliverdin. and 3. Discovery of an inevitably successful treatment for autoimmune and allergic diseases. Engaged in internal medical work since July, 1981. Started running a private internal medical clinic in September, 1989.
Urology & Nephrology CenterEgypt
He had his doctoral thesis from University of Oxford, UK. I had two years of Post doctoral training at Nantes University, France. Two years of Post Doctoral training at Northwestern University and University of Chicago, USA. Research focus on studying the transplantation immunology consequences. A)Immune tolerance of the graft; I had several studies on T regulatory cells potential post transplantation. B) Graft rejection;I am interested in studying the role of B cells in chronic rejection, I have developed a new flowcytometry assay based on microbeads technology to isolate HLA-donor specific B cells, and study the characteristics of donor specific B cells at the single cellular level. C) Prediction of long term graft outcome; my work focus on the development of clinically applicable biostatistical models and I have several clinical publications in Transplantation and Cancer.
National Research center CairoEgypt
Professor Dr. Gmail SG Zeedan has obtained his PhD from Cairo University Egypt in Virology. He also did his course in Micro biology too. He's working in National Research Center in the same university of Cairo as Associated Professor. Gmail has work experience too, he worked as Assistant Professor in Micro biology, Virology in faculty of medicine. and also has teaching experience for the medical Micro Biology, Virology, Diagnostic, Micro biology. His interests are student training in Immunology and molecular biology, Molecular diagnosis. He published many publications in reputed journals supervising postgraduate students and serving as an editorial board member of reputed journals. His research focuses on the Molecular Typing and Epidemiological Studies of Viruses and Bactria of Animal Origin with Special Interest of Antibacterial and Antiviral Agents.
Chungbuk National UniversitySouth Korea
Chong-Kil Lee Did his Ph.D from Department of Microbiology and Immunology, University of The Chicago Medical School,IL, USA. Currently his working as a professor in Chungbuk National University, South korea. Efficient generation of tolerogenic dendritic cells, Modulation of MHC-restricted antigen presentation, Immunomodulatory activities of natural products.
Nasr-Eldin Mohamed M. Aref graduated from faculty of Veterinary Medicine at Assiut University-Egypt in 1994. He obtained his master degree in Internal Veterinary Medicine from the same faculty in 1998 with special emphasis on neonatal calf diarrhea, acid-base balance and rehydration therapy. His Ph.D. in Large Animal Clinical Sciences from College of Veterinary Medicine at Michigan State University, USA in 2008 focused on construction of highly immunogenic heat-stable enterotoxin (STa) of enterotoxigenic Escherichia coli (ETEC) strains.A patent out of his Ph.D. work has been issued in USA. He has several articles published in International and local journals. He is a reviewer in several international journals: Journal of Pharmaceutical Sciences, Toxins, Scandinavian Journal of Infectious Diseases, African Journal of Microbiology Research and Journal of Microbiology and Immunology.Dr. Aref's scholarly work is geared towards enterotoxin-mediated diarrheal diseases and development of ST-based ETEC vaccine using nanotechnology. Dr. Aref is currently holding a position of Vice Dean for Education and Student Affairs, Faculty of Veterinary Medicine, New Valley, Assiut University-Egypt. Research interess are Heat Stable Enterotoxin of ETEC, Clinical immunology, Body fluid and acid base balance, Neonatal Diseases
Dr. Yongxin Zhang, CEO of Zyxell Inc., graduated from Beijing Medical University for both of his MD (1983) and PhD (1989), and received postdoctoral training in Baylor College of Medicine (1996-2004). He has the expertise in the research of immunology, especially in cancer cell therapy. His research work on aging immunology revealed the mechnisim of the compromised immune responses in aged subjects and exhibited the preventive effects of ex vivo reactivated and expanded lymphocytes on influenza virus infection in aged animals. He is also the inventor of ZYX Bioreactor, which has a great advantages in expansion of immunocytes and hepatopoiethic stem cells over other systems. He has more than 30 publications in peer-reviewed journals.
University of Milano-BicoccaItaly
Dr. Maria FOTI graduated in Milan and obtained her PhD in Biotechnology at the University of Milan. She studied the molecular mechanisms associated to early events during dendritic cells activation and maturation. From these studies a role of dendritic cells in innate immunity is suggested. From 1999-2003 she was appointed as researcher at the R and D Department of the pharmaceutical company Bayer in Milan where she focused on early-stage target discovery in the field of immunology. She set up the functional genomics laboratory to start projects for the selection of biomarkers using the microarray technology in the field of Immunology, cancer and toxicology.From 2004 she became assistant professor at the University of Milano-Bicocca where she headed the Research Team of Genopolis, a public Consortium devoted to functional Genomics studies. Her current research work is mainly devoted to the understanding of the molecular mechanisms underlying the pathophysiology of autoimmune diseases. The goal of the research group in this area is to develop blood-based diagnostic for Autoimmune diseases such as Multiple Sclerosis and Type I Diabetes by using expression profiling and epigenomics approaches. She serves as reviewer for scientific journals and as scientific advisor for grant review committees.Her current research work is mainly devoted to the understanding of the molecular mechanisms underlying the pathophysiology of autoimmune diseases. The goal of the research group in this area is to develop blood-based diagnostic for Autoimmune diseases such as Multiple Sclerosis and Type I Diabetes by using expression profiling and epigenomics approaches.
Instituto Oswaldo CruzBrazil
Paulo Antas did his Ph.D. in Infectious Diseases,TB at Oswaldo Cruz Institute, FIOCRUZ, Brazil.He is currently working at Laboratrio de Imunologia Clnical,Departamento de Imunologia,Instituto Oswaldo Cruz, FIOCRUZ,Av. Brasil 4365, Rio de Janeiro, Brazil.He also worked as Associate Professor (Parasitology course) in FOA University, Brazil.He is a Member of the Editorial Board of the MAYFEB Journal of Medicine and also Member of the Editorial Board of the Austin Journal of Clinical Immunology 2016.His research interests are as follows: protein profiles and serological stages in Trypanosoma cruzi-infected children in Bolivian endemic areas for Chagas Disease. cellular immune response in Mycobacterium tuberculosis.
Zafar Mahmood obtained his Ph.D. in Infection and Immunity section from Graduate school of Life sciences, University of Wuerzburg, Germany with Magna cum Lauda. He doctoral work on done in Department of Rheumatology and clinical immunology focused on autoimmune diseases. Before working in the field of human immunology, he also worked in the areas of cancer biomarker, chemoprevention and toxico-proteomics. During his research, several articles are published with high citation rate. Death receptor: target as cancer therapy was second most cited paper of the year. During his doctoral he has been awarded with several prestigious scholarship and travel grants to present his work and actively participate throughout worldwide.Currently he is based at Emory university, Atlanta and mainly focus on Mechanism of immune cells in autoimmune diseases in human. His research interests are microbiology, immunology, autoimmunity, tumor-cancer research and toxicology
Chung Shan Medical UniversityTaiwan
Tsai-Ching Hsu done his Ph.D from Institute of Medicine, Chung Shan Medical University, Taiwan. Currently his working as a Director, Institute of Microbiology and Immunology, Chung Shan Medical University, Taiwan.2011-2015 Professor, Institute of Microbiology and Immunology, Chung Shan Medical University, Taiwan. Research interests are as follows Medicine, Immunology, Infection and Immunity, Autoimmune diseases.
Research Institute Veterinary De TunisTunisia
Sami Lakhal Did his PhD from University of Tunis El Manar Tunis. Diploma of Advanced Studies in Genetics and Molecular Biology obtained with honors Well Project entitled Immunogenicity study and the protective effect of a vaccine using the P20 protein of Leishmania infantum, using laboratory mice as experimental hosts, conducted within the Institut Pasteur in Tunis, under the co-supervision of Pr. Chenik Mehdi and Pr Hechmi Louzir, Faculty of Mathematical, Physical and Natural Sciences of Tunis University of Tunis El Manar. His Research Intrests are As a resident in Tunisia where both dermotropic and viscerotropic Leishmania species were shown to perpetuate through blood feeding phlebotomine flies and mammals-such as wild rodents, canids and human beings, over the last twenty years, the Leishmania genus became the single-celled eukaryotic parasite which first triggered my training period as a researcher.
Sabzevar University of Medical SciencesIran
Faham Khamesipour received his D.V.M. from Islamic Azad University of Veterinary Medicine, as well as a DVSc-PhD in parasitology from the Shiraz University. In 2013, he entered Young Researchers and elite club,where he was trained as a researcher focusing on zoonotic disease. In 2015,he entered Cellular and molecular research center of Sabzevar University of Medical sciences, where he was trained as a researcher focusing on zoonotic disease. Areas of expertise include research and disease outbreak investigations involving zoonotic disease and parasitology. His research intrests are Zoonotic disease and parasitology.
Shanghai Jiao Tong University School of Medicine ShanghaiChina
Huihua Ding did her MD from Peking Union Medical College, Beijing, China.Currently She is working as a Visiting Research Fellow, Biomedical Engineering Department, University of Houston, Houston, TX, USA. 1)Ding H, Mohan C. Connective tissue diseases: Promises and challenges of metabolomics in SLE. Nature Reviews Rheumatology. 2)Wu T, Ding H, Han J, Arriens C, Wei C, Han W, Pedroza C, Jiang S, Anolik J, Petri M, Sanz I. Antibody array based proteomic screening of serum markers in systemic lupus erythematosus a discovery study. Journal of proteome research. Her Research intrests are Novel biomarkers identification in rheumatic diseases 2)Pathogenic mechanisms of systemic lupus erythematosus (SLE). Reviewer for International Journal of Rheumatic Diseases
Northwell Health, ManhassetUSA
Tiwari Mukesh is currently working as a researcher and Clinical Laboratory Manager at Northwell Health, Manhasset, New York and will very likely be a useful addition to your editorial team.He has been working in the field of pancreatic islet cell therapy and transplantation for autologous, allogeneic and xenotransplantation uses for chronic pancreatitis and Type-1 Diabetes Mellitus since 2009 and has sound knowledge and experience of the subject matter. I have had the opportunity to supervise and mentor him previously and work closely on various aspects of basic and clinical research with him.Mukesh has published several papers in journals such as American journal of transplantation (AJT), European Medical Journal (EMJ) Transplantation, Pancreatology, Acta Diabetologia, Journal of Diabetes Science and Technology & Transplantation Proceedings.
University of MisanIraq
Defence Research & Development EstablishmentIndia
Shailendra K Verma (PhD) is senior scientist at Defence Research and Development Establishment, Gwalior, India. Dr. Verma received his PhD in Biotechnology from Central Drug Research Institute, Lucknow, India. Dr. Verma completed postdoctoral research at University of Nebraska Medical Center, Omaha, Nebraska and University of Tennessee Health Science Center, Memphis, USA. His current research area focussed onto the pathogenesis of Y. pestis in small animal model and to develop subunit vaccine and therapeutics against plague.
Institute of Bioresoures & Sustainable Development (IBSD) Sikkim Centre India
Laishram Shantikumar Singh earned his graduate and post degree in Microbiology from Bangalore University, Bangaluru, India and received his PhD degree in the field of Microbial Biotechnology from Dibrugarh University, India through research work at CSIR-NEIST, Jorhat, Assam, India. Currently he is serving as Scientist, Microbial Biotechnology in Institute of Bioresources and Sustainable Development, Sikkim Centre, DBT, Govt. of India, Gangtok, Sikkim, India. His research interests are as follows: 1. Microbial Diversity 2. Bioactive compound and antimicrobial agents from actinomycetes, endophytes 3. Biopesticides and plant pathogens of certain crops 4. Plant endophytes relation 5. Fight against drug resistant and opportunistic pathogens 6. Antimicrobial potential of medicinal plants 7. Chemical Ecology of Endophytes .